Search filters

List of works by Maria Antonietta Aloe Spiriti

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

scientific article

A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders

scientific article published on 01 October 2000

Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma

scientific article published on 01 April 2008

Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia

scientific article published on 22 May 2008

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.

scientific article published on 16 September 2012

Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion

scientific article published on 17 May 2010

Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): study and review of literature.

scientific article published on 24 June 2013

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

scientific article published on 12 March 2015

Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro.

scientific article published in August 2002

High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.

scientific article published on 26 June 2003

Histological recovery and gluten-free diet adherence: a prospective 1-year follow-up study of adult patients with coeliac disease

scientific article published on 28 July 2014

Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?

scientific article published on 20 September 2008

Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy

scientific article

Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile

scientific article published on 28 February 2014

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

scientific article

Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

scientific article published on 20 March 2014

Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia

scientific article published on 01 September 2006

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

scientific article

Unbalanced 6p translocation as primary karyotypic anomaly in secondary acute nonlymphocytic leukemia

scientific article published on May 1, 1992